Extracellular Vesicles for Rejection Monitoring in Cardiac Transplantation
Recruiting
Observational Study
Rejection Heart Transplant
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 30 (estimated)
- Sponsor
- Laurenz Kopp Fernandes · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study will analyze extracellular vesicle (EV)-derived protein profiles in heart transplantated patients during the first 15 months post-transplantation to investigate, if there are distinct EV-derived proteins or protein patterns that allow early and reliable diagnosis of acute cardiac allograft rejection. Additionally, it will explore temporal changes in the EV-derived protein profile during…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Subject is either on the heart transplant waiting list or is still hospitalised following HTx surgery.
* Age of subject is ≥ 18 years.
* Subject is female or male.
* Capacity to consent.
* Signed written informed consent.
* For female subjects:
1. Confirmed post-menopausal …
Contacts